Marlies has graduated!
Back in Groningen, in the north of the Netherlands, Marlies Oomen has obtained her masters degree in Biology and celebrated after her graduation ceremony. Now a licensed biologist, Marlies will re-enter the Dekker lab as the newest grad student. We are excited for her return! We do however, feel a bit sorry for her, as she will once again come in to face the Worcester winter…
Marlies (far left) after graduation ceremony
Dr. Amartya Sanyal has left the lab to start his own lab at the School of Biological Sciences and Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. We will miss him, but we are very excited for him!. Go Amartypedia!
Dr. Sanyal’s website
Jon has graduated! After popping the champagne he is going to work for Illumina in San Diego.
Jennifer E. Phillips-Cremins, Ph.D. is a newly-arrived (January 2014) Assistant Professor of Bioengineering at the University of Pennsylvania. During her Ph.D. candidacy at Georgia Institute of Technology, Dr. Cremins was funded by a National Science Foundation Graduate Research Fellowship to develop transcription factor-based genetic engineering strategies for the direct conversion of dermal fibroblasts into mature bone cells. She was then funded by an NIH National Research Service Award to conduct a unique multi-disciplinary postdoc that simultaneously spanned three institutions and four independent laboratories with the goal of generating the first high-resolution 3-D genome architecture maps in mouse embryonic stem cells.
Dr. Cremins now runs the 3-D Epigenomics and Systems Neurobiology laboratory at UPenn. Her lab focuses on understanding the epigenetic mechanisms that govern phenotype commitment in healthy neurons and how these epigenetic mechanisms go awry during the onset of neurodegenerative diseases. She runs a quantitative wet lab that employs both state-of-the-art molecular and bioinformatics tools to map and study epigenetic modifications and higher-order genome folding in a genome-wide manner. Current work is focused on understanding the epigenetic mechanisms that regulate the differentiation of embryonic stem cells into neurons and the reprogramming of healthy and diseased neurons in the reverse direction back into induced pluripotent stem cells. The long-term goal of the Cremins lab is to engineer and manipulate chromatin architecture to control cellular phenotype for regenerative medicine and neurodegenerative disease treatment applications.